(Q33366800)

26 July 2017

1 reference

title

Intravenous immunoglobulin in neurological disorders: a mechanistic perspective (English)

1 reference

Sébastien Lacroix-Desmazes

26 July 2017

Antonino Nicoletti

9

0 references

object named as

Sebastien Lacroix-Desmazes

8

0 references

Jagadeesh Bayry

object named as

Jagadeesh Bayry

2

0 references

Suryasarathi Dasgupta

4

object named as

Suryasarathi Dasgupta

1 reference

26 July 2017

5

Sandrine Delignat

1 reference

26 July 2017

10

Michel D Kazatchkine

1 reference

26 July 2017

11

Srini V Kaveri

1 reference

26 July 2017

Namita Misra

1

1 reference

26 July 2017

Amal Ephrem

3

1 reference

26 July 2017

Jean-Paul Duong Van Huyen

6

1 reference

26 July 2017

Fabienne Prost

7

1 reference

26 July 2017

1 May 2005

1 reference

26 July 2017

1 reference

26 July 2017

252 Suppl 1

1 reference

26 July 2017

I1-6

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-005-1102-7

26 July 2017

0 references

cites work

Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00415-005-1102-7

Intravenous immune globulin therapy for neurologic diseases

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00415-005-1102-7

I.v. immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barré syndrome

21 January 2018

1 reference

12 December 2020

Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment.

1 reference

12 December 2020

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

1 reference

12 December 2020

Immunomodulatory action of intravenous immunoglobulin.

1 reference

12 December 2020

Pooled human IgG modulates cytokine production in lymphocytes and monocytes.

1 reference

12 December 2020

Anti-CD4 activity of normal human immunoglobulin G for therapeutic use. (Intravenous immunoglobulin, IVIg)

1 reference

12 December 2020

Normal immunoglobulin G protects against experimental allergic encephalomyelitis by inducing transferable T cell unresponsiveness to myelin basic protein.

1 reference

12 December 2020

Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway

1 reference

12 December 2020

Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg)

1 reference

12 December 2020

Natural antibodies sustain differentiation and maturation of human dendritic cells

1 reference

12 December 2020

Phosphorylation of Bcl-2 and mitochondrial changes are associated with apoptosis of lymphoblastoid cells induced by normal immunoglobulin G

1 reference

12 December 2020

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

1 reference

12 December 2020

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

1 reference

12 December 2020

F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins

1 reference

12 December 2020

Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations

1 reference

12 December 2020

Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis

1 reference

12 December 2020

Intravenous immunoglobulin abrogates dendritic cell differentiation induced by interferon-? present in serum from patients with systemic lupus erythematosus

1 reference

12 December 2020

High-Dose Intravenous Immune Globulin for Stiff-Person Syndrome

1 reference

12 December 2020

Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use.

1 reference

12 December 2020

High-avidity autoantibodies to cytokines.

1 reference

12 December 2020

Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases

1 reference

12 December 2020

The growth arresting effect of human immunoglobulin for intravenous use is mediated by antibodies recognizing membrane glycolipids

1 reference

12 December 2020

Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg).

1 reference

12 December 2020

The role of intravenous immunoglobulin in the treatment of multiple sclerosis

1 reference

12 December 2020

Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis

1 reference

12 December 2020

Intravenous immune globulin: an alternative therapy in steroid-dependent allergic diseases

1 reference

12 December 2020

Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era?

1 reference

12 December 2020

High-dose intravenous immunoglobulin treatment activates complement in vivo

1 reference

12 December 2020

Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro

1 reference

12 December 2020

Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease

1 reference

12 December 2020

IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity

1 reference

12 December 2020

V region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (i.v.Ig).

1 reference

12 December 2020

Manipulating the Immune System with Immune Globulin

1 reference

12 December 2020

Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG

1 reference

12 December 2020

Prevention of experimental autoimmune uveoretinitis by infusions of human therapeutic intravenous immunoglobulins in rats

1 reference

12 December 2020

Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin

1 reference

12 December 2020

Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group

1 reference

12 December 2020

Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain

1 reference

12 December 2020

High doses of intravenous Ig inhibit in vitro uptake of C4 fragments onto sensitized erythrocytes.

1 reference

12 December 2020

Intravenous immunoglobulin in autoimmune neuromuscular diseases

1 reference

12 December 2020

High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments

1 reference

12 December 2020

Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations

1 reference

12 December 2020

Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases

1 reference

12 December 2020

Posttranscriptional regulation of T-cell IL-2 production by human pooled immunoglobin

1 reference

12 December 2020

Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin)

1 reference

12 December 2020

Immunologically active proteins in intravenous immunoglobulin

1 reference

12 December 2020

Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level

1 reference

12 December 2020

Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis

1 reference

12 December 2020

Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages

1 reference

12 December 2020

10.1007/S00415-005-1102-7

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference